Acute lymphoblastic leukaemia associated antigen—II. Isolation and partial characterisationRobert Sutherland; John Smart; Patrick Niaudet; Melvyn Greaves · 1978

Acute lymphoblastic leukaemia (ALL) associated antigen—I. Expression in different haematopoietic malignanciesMarion Roberts; Melvyn Greaves; George Janossy; Robert Sutherland; Carol Pain · 1978

Acute lymphoblastic leukaemia associated antigen. IV Expression on non-leukaemic ‘lymphoid’ cellsMelvyn Greaves; Domenico Delia; George Janossy; Nicholas Rapson; Judith Chessells; Marilyn Woods; Grant Prentice · 1980

Expression of the platelet-common acute lymphoblastic leukaemia associated antigen on normal eosinophilsH. Ohto; Y. Shibata; A. Takeuchi; R-F. Chen; H. Maeda · 1985

Clinical significance of the presence of myeloid associated antigens in acute lymphoblastic leukaemiaAlvaro Urbano-Ispizua; Estela Matutes; Neus Villamor; Josep Maria Ribera; Evarist Feliu; Emilio Montserrat; Albert Grańtena; Joan-Lluis Vives-Corrons; Ciril Rozman · 1990

ETV6 (TEL)-AML1 pre-B acute lymphoblastic leukaemia cells are associated with a distinct antigen-presenting phenotypeAngela J. Alessandri; Gregor S. D. Reid; Sharon A. Bader; Bonnie G. Massing; Poul H. B. Sorensen; Kirk R. Schultz · 2002

Expression of a 150-kD cell surface antigen identified by monoclonal antibody YB5.B8 is associated with poor prognosis in acute non-lymphoblastic leukaemiaLeonie K. Ashman; Marion M. Roberts; Stephen J. Gadd; Samantha J. Cooper; Christopher A. Juttner · 1988